Today: 26 June 2026

Jefferies Financial Group Inc Says MFS Losses Seen Under $20 Million as Western Alliance Clash Deepens

Jefferies Financial Group Inc Says MFS Losses Seen Under $20 Million as Western Alliance Clash Deepens

Jefferies Financial Group said losses from the collapse of UK lender Market Financial Solutions would likely stay under $20 million and denied owing Western Alliance $126.4 million over First Brands loans. Jefferies shares fell about 3% Monday after Morgan Stanley downgraded the stock, citing credit and legal risks. Western Alliance sued Friday, alleging Jefferies breached a loan agreement. Jefferies said the loan was non-recourse.
9 March 2026
··
Red Cat Holdings Stock Swings After Pentagon Drone Results Cool Rally Ahead of March 18 Earnings

Red Cat Holdings Stock Swings After Pentagon Drone Results Cool Rally Ahead of March 18 Earnings

Red Cat Holdings shares fell about 4% Monday after its Teal Drones unit was listed among 11 finalists for Pentagon drone contracts, cooling a rally that sent the stock to a one-year high last week. The company expects to report fourth-quarter revenue of $24–$26.5 million on March 18, up sharply from a year earlier, but warned those figures are unaudited.
9 March 2026
····
Atara Biotherapeutics Stock Jumps 18% as FDA Shake-Up Puts Ebvallo Back in Focus

Atara Biotherapeutics Stock Jumps 18% as FDA Shake-Up Puts Ebvallo Back in Focus

Atara Biotherapeutics shares jumped 18% Monday after reports that FDA biologics chief Vinay Prasad will depart in April. The move follows the agency’s January rejection of Atara’s EBVALLO therapy for a rare blood cancer, which wiped out 56% of the stock’s value. Atara and partner Pierre Fabre have requested a Type A meeting with the FDA to revisit the decision. Atara ended 2025 with $8.5 million in cash.
9 March 2026
····
Capricor Therapeutics Stock Rises Ahead of March 12 Update as FDA Watch on Duchenne Drug Builds

Capricor Therapeutics Stock Rises Ahead of March 12 Update as FDA Watch on Duchenne Drug Builds

Capricor Therapeutics shares jumped 7.6% to $30.01 after the company set March 12 for its quarterly and annual update, spotlighting its Duchenne muscular dystrophy therapy, deramiocel. An MDA conference abstract showed deramiocel met main goals in a 106-patient Phase 3 trial, with no imbalance in severe adverse events. The FDA rejected approval in July but later requested the full study report.
9 March 2026
·
Nasdaq Partners With Kraken on Tokenized Stocks, Eyes 2027 Launch

Nasdaq Partners With Kraken on Tokenized Stocks, Eyes 2027 Launch

Nasdaq announced plans for a tokenized shares framework and will partner with Payward, parent of crypto exchange Kraken, to build a gateway linking regulated stock markets to blockchain networks. The program is set to launch in the first half of 2027. Kraken will help distribute tokenized shares in Europe and other markets outside the U.S. The plan requires SEC approval and updated market infrastructure.
9 March 2026
·····
Day One Biopharmaceuticals, Inc. Buyout: Why Servier’s $2.5 Billion Ojemda Deal Matters Now

Day One Biopharmaceuticals, Inc. Buyout: Why Servier’s $2.5 Billion Ojemda Deal Matters Now

Day One Biopharmaceuticals shares traded at $21.24 Monday, just below Servier’s $21.50-per-share cash offer in a $2.5 billion takeover. The deal would give Servier Ojemda, the only U.S.-approved single-drug treatment for pediatric low-grade glioma, with 2025 sales of $155.4 million. The tender offer has not started and closing depends on shareholder response and U.S. antitrust clearance.
9 March 2026
W&T Offshore earnings: 2025 loss widens after delay as debt falls, offshore rule relief looms

W&T Offshore earnings: 2025 loss widens after delay as debt falls, offshore rule relief looms

W&T Offshore reported a preliminary 2025 net loss of $150.1 million, up from $87.1 million in 2024, as revenue dropped to $501.5 million and free cash flow plunged to $1.5 million. Average oil selling price fell to $64.09 a barrel, though production slightly increased. Year-end liquidity rose to $184.5 million, and net debt declined. The company warned results are unaudited and may change before its March 16 filing.
9 March 2026
·
Reviva Pharmaceuticals Holdings (RVPH) Starts 1-for-20 Reverse Split as Nasdaq Deadline Nears

Reviva Pharmaceuticals Holdings (RVPH) Starts 1-for-20 Reverse Split as Nasdaq Deadline Nears

Reviva Pharmaceuticals enacted a 1-for-20 reverse stock split early Monday to boost its share price and avoid a Nasdaq delisting. The company faces a March 27 deadline to meet the $1 minimum bid rule. Reviva is also seeking funding for a new Phase 3 trial of its schizophrenia drug after the FDA requested more data. Analyst Jason Kolbert downgraded the stock, citing unchanged fundamentals.
9 March 2026
·
uniQure stock jolts higher again after FDA biologics chief set to exit

uniQure stock jolts higher again after FDA biologics chief set to exit

uniQure shares surged 34% to $14.27 in U.S. premarket trading Monday after news that FDA biologics chief Vinay Prasad will step down in April. The move follows a dispute over the agency’s demand for a new sham-surgery trial of uniQure’s Huntington’s gene therapy. The FDA has not agreed to approve the treatment based on current data. uniQure ended 2025 with $622.5 million in cash and investments.
9 March 2026
·
Oil Tops $100, Wall Street Futures Slide as Shock U.S. Jobs Data and Iran War Rattle Markets

Oil Tops $100, Wall Street Futures Slide as Shock U.S. Jobs Data and Iran War Rattle Markets

Brent crude topped $100 a barrel for the first time since 2022 as the U.S.-Israeli war with Iran disrupted the Strait of Hormuz and Gulf states cut oil output. S&P 500 futures fell 1.2% after a weak U.S. jobs report, while the VIX volatility index hit its highest since April 2025. Hundreds of tankers remained idle, and G7 finance ministers discussed a possible coordinated release of emergency oil reserves.
9 March 2026
·
3D Systems Corporation beats Q4 sales guidance, but weak Q1 outlook clouds recovery

3D Systems Corporation beats Q4 sales guidance, but weak Q1 outlook clouds recovery

3D Systems reported fourth-quarter revenue of $106.3 million, up 16% from the prior quarter and above its forecast, but still down 4% from a year earlier. Full-year revenue dropped 12% to $386.9 million, with a net income gain driven by asset sales and cost cuts. Healthcare Solutions rose 25% while Industrial Solutions fell 21%. The company expects a first-quarter revenue decline and continued losses.
9 March 2026
··
Aureus Greenway Holdings to Buy Powerus in Drone Pivot, With $9 Million Raise

Aureus Greenway Holdings to Buy Powerus in Drone Pivot, With $9 Million Raise

Aureus Greenway Holdings will acquire drone maker Powerus in an all-stock deal to take it public, renaming the combined company Powerus Corp and targeting a summer 2026 Nasdaq listing as PUSA. South Korea's KCGI committed to buy $50 million in Powerus stock, while Aureus arranged $9 million in new financing. The deal still requires SEC and shareholder approval. AGH shares rose 12.8% in premarket trading.
9 March 2026
·
US Stock Market Open Today: Oil Nears $120, Futures Slide and Fed Cut Bets Fade

US Stock Market Open Today: Oil Nears $120, Futures Slide and Fed Cut Bets Fade

U.S. stock futures fell sharply Monday as oil neared $120 a barrel, stoking inflation fears amid ongoing Middle East conflict. February jobs data showed a loss of 92,000 jobs and unemployment rising to 4.4%. Brent crude briefly hit $119, and the VIX touched its highest level since April 2025. G7 finance ministers plan to discuss a coordinated emergency oil release.
9 March 2026
··
Canada Stock Market Today: What to Know Before the TSX Open as Oil Shock Hits Banks, Miners

Canada Stock Market Today: What to Know Before the TSX Open as Oil Shock Hits Banks, Miners

Canada’s TSX index was set to open lower Monday, with futures down 0.92% after Brent crude touched $119.50 a barrel amid war involving Iran. The TSX had fallen 3.7% last week, its worst in over a month, as traders worried oil’s surge would fuel inflation. Wall Street futures dropped over 1%, and the VIX volatility index hit its highest since April 2025. Gold and base metals slipped, while financials faced scrutiny over condo appraisal practices.
9 March 2026
···
Silver Price Today: Why Silver Slipped to $84 as Dollar Surge and Oil Shock Rattle Markets

Silver Price Today: Why Silver Slipped to $84 as Dollar Surge and Oil Shock Rattle Markets

Spot silver fell 0.3% to $84.07 an ounce Monday after earlier losses of over 5%, as oil surged to $119.50 a barrel amid escalating conflict between the U.S., Israel, and Iran. Investors rushed to cash and the dollar strengthened, pushing back expectations for a U.S. rate cut to September or October. European and Asian markets also braced for more rate hikes as inflation fears mounted.
9 March 2026
·
Gold price today slides from $5,100 as oil shock lifts dollar, rate fears

Gold price today slides from $5,100 as oil shock lifts dollar, rate fears

Spot gold dropped 1.2% to $5,109.39/oz by 10:12 GMT Monday as a stronger dollar and surging oil prices pressured markets amid the U.S.-Israel-Iran war. Brent oil briefly hit $119.50 a barrel, reviving inflation fears and reducing bets on near-term U.S. rate cuts. Silver eased to $84.07/oz, while platinum and palladium also fell. U.S. stock futures and sterling declined as investors sought safety in the dollar.
9 March 2026
·
Hims & Hers Stock Surges on Report Novo Nordisk Will Return to Sell Wegovy on Its Platform

Hims & Hers Stock Surges on Report Novo Nordisk Will Return to Sell Wegovy on Its Platform

Hims & Hers Health shares jumped premarket Monday after reports that Novo Nordisk will sell weight-loss drugs through its platform, with an announcement expected the same day. The move follows a recent patent dispute and comes as the FDA increases scrutiny of compounded GLP-1 drugs. Hims previously pulled a compounded Wegovy pill after FDA threats and a Novo lawsuit. The companies had partnered before but split last June over marketing concerns.
9 March 2026
···
1 … 310 311 312 313 314 … 2,109

Stock Market Today

  • Hong Kong's 24-Hour Stock Trading Debate: Liquidity and Price Discovery Concerns
    June 26, 2026, 1:34 AM EDT. Hong Kong faces calls for 24-hour stock trading to boost global competitiveness, following moves by Nasdaq and Korea Exchange. However, experts warn extended hours may dilute liquidity, impacting price discovery and increasing volatility. Current trading is concentrated around defined daily sessions with a closing price as a benchmark for index funds managing trillions. A 24-hour market raises questions about defining closing prices and risks turning trading into prolonged after-hours sessions. Market makers may face greater risk holding positions longer due to thinner liquidity, potentially raising trading costs for investors. The debate highlights challenges balancing investor demand for accessibility with market stability.

Latest News

Bloom Energy (NYSE:BE) trades choppy after Russell Top 200 adds the AI play

Bloom Energy (NYSE:BE) trades choppy after Russell Top 200 adds the AI play

25 June 2026
Bloom Energy plunged 5.2% as it prepares to exit the Russell 2000 and join the Russell Top 200 after a 1,000% stock surge, forcing index funds to rebalance amid a $15 billion one-day equity swing; at $309.18, shares trade 24 times the midpoint of its 2026 revenue guide, still 12% above Barclays’ new target.
Figma drops ahead of Russell close with valuation gap stretching

Figma drops ahead of Russell close with valuation gap stretching

25 June 2026
Figma (NYSE:FIG) plunged 9.8% to $16.84—just above its 52-week low—on heavy volume ahead of its addition to the Russell 3000 after Friday’s close, with index funds tracking $12.2 trillion set to rebalance; Figma now trades at about 5x its 2026 revenue guide, 49% below its IPO price, despite 46% Q1 revenue growth and raised guidance, as analysts cite mixed ratings and persistent losses.
Bitcoin Holds $80,000 as ETF Outflows Put Rally Back on Trial

Bitcoin slips near $59,500 as ETF outflows hit options support

25 June 2026
U.S. spot bitcoin ETFs saw $469 million in net outflows on June 24, with IBIT and FBTC accounting for about 77% of the total, sending IBIT down 1.1% and MSTR plunging 9.3%; Citi says ETF flows explain 45% of weekly BTC return variation, highlighting outflows as a key signal for investor sentiment as bitcoin tests the high-$50,000s.
Go toTop